e-learning
resources
London 2016
Tuesday, 06.09.2016
Malignant pleural disease: diagnosis and management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: Efficacy and safety profile of autologous blood versus talc pleurodesis for malignant pleural effusion
Apichat Kaewdech (Songkla, Thailand), Apichat Kaewdech, Warangkana Keeratichananont
Source:
International Congress 2016 – Malignant pleural disease: diagnosis and management
Session:
Malignant pleural disease: diagnosis and management
Session type:
Poster Discussion
Number:
3398
Disease area:
Respiratory infections, Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Apichat Kaewdech (Songkla, Thailand), Apichat Kaewdech, Warangkana Keeratichananont. LATE-BREAKING ABSTRACT: Efficacy and safety profile of autologous blood versus talc pleurodesis for malignant pleural effusion. Eur Respir J 2016; 48: Suppl. 60, 3398
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of solitary fibrous tumours of the pleura: a systematic review and meta-analysis
Utility of pleural fluid for predictive marker testing in malignant pleural effusion
Massive pleural effusion presented with a very rare multitude of complication
Related content which might interest you:
LATE-BREAKING ABSTRACT: Impact of NSAIDs on success of chemical pleurodesis in malignant pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016
Pleurodesis success rate for malignant pleural effusions - talc slurry vs. poudrage
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016
An examination of the factors for successful pleurodesis against malignant pleural effusion (MPE)
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016
Outcomes of bedside talc slurry pleurodesis for malignant pleural effusions: A retrospective analysis
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013
LATE-BREAKING ABSTRACT: A proteomic study of benign and malignant pleural effusions
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015
Thoracoscopic talc Poudrage pleurodesis for malignant effusions
Source: International Congress 2015 – Interventional pulmonology for pleural diseases
Year: 2015
Hemorrhagic malignant pleural effusion: Diagnosis, survival rate, and response to talc pleurodesis
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014
What outcome after pleurodesis in malignant pleural effusion in lung cancer?
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015
Outcomes of the management of malignant pleural effusions with talc poudrage or talc slurry following medical thoracoscopy
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015
Talc pleurodesis for malignant pleural effusion - effect on survival: Case-control follow-up study
Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma
Year: 2014
Predictive parameters of survival in malignant pleural effusion
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015
Blood-staining of pleural fluid is an inaccurate predictor of pleural malignancy
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015
Iodopovidone pleurodesis in malignant pleural effusion: Is tube clamping time affected the efficacy & safety?
Source: Annual Congress 2013 –Chest wall and pleura
Year: 2013
Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions
Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management
Year: 2015
LATE-BREAKING ABSTRACT: Cytoreduction surgery and hypertermic intraoperative intrapleural chemotherapy for malignant pleural diseases: initial experience
Source: International Congress 2014 – Risk assessment and tracheal reconstructions
Year: 2014
A novel pleural-bladder pump for management of pleural effusion
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013
Utility of sending pleural fluid for cytology at the time of thoracoscopy and pleural biopsy
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016
Malignant pleural effusion (MPE) as debut of cancer
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015
Tunneled indwelling pleural catheter (TPC) in recurrent malignant pleural effusions: A retrospective study of 230 patients
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014
Ideal volume sampling in the diagnosis of malignant pleural effusions. Just how much is really enough?
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept